X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15) 15
female (12) 12
breast cancer (10) 10
oncology (10) 10
medical and health sciences (9) 9
medicin och hälsovetenskap (9) 9
index medicus (8) 8
ovarian cancer (8) 8
mutation (7) 7
biochemistry & molecular biology (6) 6
cancer and oncology (6) 6
cancer och onkologi (6) 6
research (6) 6
cancer (5) 5
clinical medicine (5) 5
genetic aspects (5) 5
genetic predisposition to disease (5) 5
histone deacetylase inhibitors (5) 5
klinisk medicin (5) 5
middle aged (5) 5
adult (4) 4
aged (4) 4
breast neoplasms - genetics (4) 4
breast neoplasms - pathology (4) 4
expression (4) 4
genes, brca1 (4) 4
genes, brca2 (4) 4
hydroxamic acids - pharmacology (4) 4
ovarian neoplasms - genetics (4) 4
phosphorylation (4) 4
skin and connective tissue diseases (4) 4
1112 oncology and carcinogenesis (3) 3
analysis (3) 3
animals (3) 3
article (3) 3
biology (3) 3
brca mutations (3) 3
brca1 (3) 3
brca1 protein (3) 3
breast neoplasms (3) 3
cell cycle - drug effects (3) 3
cell line, tumor (3) 3
cyclin d1 (3) 3
cyclin d1 - genetics (3) 3
cyclin d1 - metabolism (3) 3
endocrine system diseases (3) 3
enzyme inhibitors (3) 3
enzyme inhibitors - pharmacology (3) 3
family (3) 3
genetic screening (3) 3
genotype (3) 3
heterozygote (3) 3
hydroxamic acids (3) 3
leupeptins - pharmacology (3) 3
life sciences & biomedicine (3) 3
medical research (3) 3
medicine (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
oncology & carcinogenesis (3) 3
oncology, experimental (3) 3
ovarian neoplasms - pathology (3) 3
science & technology (3) 3
activation (2) 2
age (2) 2
aged, 80 and over (2) 2
akt (2) 2
amino-acid polymorphism (2) 2
brca1 protein - genetics (2) 2
breast (2) 2
breast-cancer (2) 2
cancer cells (2) 2
carcinoma (2) 2
cell cycle (2) 2
cell nucleus (2) 2
cell nucleus - metabolism (2) 2
common variants (2) 2
complex (2) 2
consortium (2) 2
cyclin d1 - antagonists & inhibitors (2) 2
cytoplasm (2) 2
cytoplasm - metabolism (2) 2
diagnosis (2) 2
dna (2) 2
epidemiology (2) 2
fatty acids, unsaturated (2) 2
genetic testing (2) 2
genetics & heredity (2) 2
germ-line mutation (2) 2
germline mutations (2) 2
glycogen synthase kinase 3 (2) 2
glycogen synthase kinase 3 - metabolism (2) 2
glycogen synthase kinase 3 beta (2) 2
human genetics (2) 2
igf (2) 2
in-vitro (2) 2
insulin (2) 2
karyopherins (2) 2
karyopherins - metabolism (2) 2
leupeptins (2) 2
life sciences (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 12/2004, Volume 10, Issue 23, pp. 8094 - 8104
Journal Article
by Couch, Fergus J and Wang, Xianshu and McGuffog, Lesley and Lee, Anew and Olswold, Curtis and Kuchenbaecker, Karoline B and Soucy, Penny and Fredericksen, Zachary and Barrowdale, Daniel and Dennis, Joe and Gaudet, Mia M and Dicks, Ed and Kosel, Matthew and Healey, Sue and Sinilnikova, Olga M and Lee, Adam and Bacot, François and Vincent, Daniel and Hogervorst, Frans B. L and Peock, Susan and Stoppa-Lyonnet, Dominique and Jakubowska, Anna and Radice, Paolo and Schmutzler, Rita Katharina and Domchek, Susan M and Piedmonte, Marion and Singer, Christian F and Friedman, Eitan and Thomassen, Mads and Hansen, Thomas V. O and Neuhausen, Susan L and Szabo, Csilla I and Blanco, Ignacio and Greene, Mark H and Karlan, Beth Y and Garber, Judy and Phelan, Catherine M and Weitzel, Jeffrey N and Montagna, Marco and Olah, Edith and Anulis, Irene L and Godwin, Anew K and Yannoukakos, koulis and Goldgar, David E and Caldes, Trinidad and Nevanlinna, Heli and Osorio, Ana and Terry, Mary Beth and Daly, Mary B and van Rensburg, Elizabeth J and Hamann, Ute and Ramus, Susan J and Toland, Amanda Ewart and Caligo, Maria A and Olopade, Olufunmilayo I and Tung, Nadine and Claes, Kathleen and Beattie, Mary S and Southey, Melissa C and Imyanitov, Evgeny N and Tischkowitz, Marc and Janavicius, Ramunas and John, Esther M and Kwong, Ava and Diez, Orland and Balmaña, Judith and Barkardottir, Rosa B and Arun, Banu K and Rennert, Gad and teo, Soo-Hwang and Ganz, Patricia A and Campbell, Ian and van der Hout, Annemarie H and van Deurzen, Carolien H. M and Seynaeve, Caroline and Gómez Garcia, Encarna B and van Leeuwen, Flora E and Meijers-Heijboer, Hanne E. J and Gille, Johannes J. P and Ausems, Margreet G. E. M and Blok, Marinus J and Ligtenberg, Marjolijn J. L and Rookus, Matti A and Devilee, Peter and Verhoef, Senno and van Os, Theo A. M and Wijnen, Juul T and Frost, Debra and Ellis, Steve and Fineberg, Elena and Platte, Radka and Evans, D. Gareth and Izatt, Louise and Eeles, Rosalind A and Adlard, Julian and Eccles, Diana M and Cook, Jackie and Brewer, Carole and Douglas, Fiona and Hodgson, Shirley and ... and KConFab Investigators and Ontario Canc Genetics Network and EMBRACE and GEMO Study Collaborators and CIMBA and HEBON and BCFR and SWE-BRCA and Ontario Cancer Genetics Network and kConFab Investigators and on behalf of CIMBA and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Onkologi and Hälsouniversitetet
PLoS genetics, ISSN 1553-7390, 2013, Volume 9, Issue 3, p. e1003212
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 7/2012, Volume 134, Issue 1, pp. 353 - 362
In spite the close association of the triple-negative breast cancer immunophenotype with hereditary breast cancers and the BRCA1 pathway, there is a lack of... 
Oncology | Hereditary breast–ovarian cancer | BRCA1 | Genetic testing | Medicine & Public Health | Triple-negative breast cancer | Hereditary breast-ovarian cancer | GENOMIC REARRANGEMENTS | FOUNDER MUTATIONS | ESTROGEN-RECEPTOR | PACLITAXEL | EPIRUBICIN | ONCOLOGY | RANDOMIZED PHASE-III | GERMLINE MUTATIONS | DENSE SEQUENTIAL CHEMOTHERAPY | YOUNG-WOMEN | CMF | Carcinoma, Ductal, Breast - genetics | Receptors, Estrogen - metabolism | Carcinoma, Ductal, Breast - epidemiology | Genetic Testing | Prevalence | Hereditary Breast and Ovarian Cancer Syndrome - diagnosis | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Carcinoma, Lobular - epidemiology | Hereditary Breast and Ovarian Cancer Syndrome - metabolism | Patient Selection | Receptors, Progesterone - metabolism | Young Adult | Carcinoma, Lobular - genetics | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Carcinoma, Ductal, Breast - metabolism | Hereditary Breast and Ovarian Cancer Syndrome - genetics | Carcinoma, Lobular - diagnosis | Carcinoma, Ductal, Breast - diagnosis | BRCA1 Protein - genetics | Heterozygote | Aged | Carcinoma, Lobular - metabolism | Hereditary Breast and Ovarian Cancer Syndrome - epidemiology | Mutation | BRCA mutations | Oncology, Experimental | Breast cancer | Research | Toy industry | Genetic screening | Prevalence studies (Epidemiology) | Ovarian cancer | Analysis | DNA | Genetic aspects | Diagnosis | Cancer
Journal Article
Oncogene, ISSN 0950-9232, 05/2010, Volume 29, Issue 20, pp. 2983 - 2995
In this study, we investigated the regulation of FOXM1 expression by estrogen receptor alpha (ER alpha) and its role in hormonal therapy and endocrine... 
Estrogen receptor | Forkhead | Endocrine resistance | Breast cancer | Transcription | FOXM1 | FACTOR HFH-11B | transcription | estrogen receptor | endocrine resistance | CYCLIN D1 | REGULATED GENES | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOUSE | breast cancer | forkhead | CELL-LINES | CELL BIOLOGY | ONCOLOGY | ESTROGEN-RECEPTOR-ALPHA | GENETICS & HEREDITY | HEPATOCYTE ENTRY | S-PHASE | GROWTH-FACTOR | EXPRESSION
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, p. e58182
Journal Article
Journal Article
Journal Article
by Ding, Yuan C and McGuffog, Lesley and Healey, Sue and Friedman, Eitan and Laitman, Yael and Paluch-Shimon, Shani and Kaufman, Bella and Liljegren, Annelie and Lindblom, Annika and Olsson, Håkan and Kristoffersson, Ulf and Stenmark-Askmalm, Marie and Melin, Beatrice and Domchek, Susan M and Nathanson, Katherine L and Rebbeck, Timothy R and Jakubowska, Anna and Lubinski, Jan and Jaworska, Katarzyna and Durda, Katarzyna and Gronwald, Jacek and Huzarski, Tomasz and Cybulski, Cezary and Byrski, Tomasz and Osorio, Ana and Cajal, Teresa Ramóny and Stavropoulou, Alexana V and Benítez, Javier and Hamann, Ute and Rookus, Matti and Aalfs, Cora M and de Lange, Judith L and Meijers-Heijboer, Hanne E. J and Oosterwijk, Jan C and van Asperen, Christi J and Gómez García, Encarna B and Hoogerbrugge, Nicoline and Jager, Agnes and van der Luijt, Rob B and Easton, Douglas F and Peock, Susan and Frost, Debra and Ellis, Steve D and Platte, Radka and Fineberg, Elena and Evans, D. Gareth and Lalloo, Fiona and Izatt, Louise and Eeles, Ros and Adlard, Julian and Davidson, Rosemarie and Eccles, Diana and Cole, Trevor and Cook, Jackie and Brewer, Carole and Tischkowitz, Marc and Godwin, Anew K and Pathak, Harsh and Stoppa-Lyonnet, Dominique and Sinilnikova, Olga M and Mazoyer, Sylvie and Barjhoux, Laure and Léoné, Mélanie and Gauthier-Villars, Marion and Caux-Moncoutier, Virginie and de Pauw, Antoine and Hardouin, Agnès and Berthet, Pascaline and yfus, Hélène and Ferrer, Sana Fert and Collonge-Rame, Marie-Agnès and Sokolowska, Johanna and Buys, Sauna and Daly, Mary and Miron, Alex and Terry, Mary Beth and Chung, Wendy and John, Esther M and Southey, Melissa and Goldgar, David and Singer, Christian F and tea, Muy-Kheng Maria and Gschwantler-Kaulich, Daphne and Fink-Retter, Anneliese and Hansen, Thomas V. O and Ejlertsen, Bent and Johannsson, Oskar T and Offit, Kenneth and Sarrel, Kara and Gaudet, Mia M and Vijai, Joseph and Robson, Mark and Piedmonte, Marion R and Anews, Lesley and Cohn, David and DeMars, Leslie R and DiSilvestro, Paul and Roiguez, Gustavo and Toland, Amanda Ewart and Montagna, Marco and ... and KConFab Investigators and EMBRACE and GEMO Study Collaborators and Consortium Investigators Modifiers and HEBON and OCGN and SWE-BRCA and Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) and for EMBRACE and for HEBON and on behalf of Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) and for GEMO Study Collaborators and for KConFab Investigators and for SWE-BRCA and for OCGN and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Diagnostikcentrum and Klinisk patologi och klinisk genetik and Östergötlands Läns Landsting and Onkologi and Hälsouniversitetet
Cancer epidemiology, biomarkers & prevention, ISSN 1055-9965, 2012, Volume 21, Issue 8, pp. 1362 - 1370
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2004, Volume 10, Issue 23, pp. 8094 - 8104
PURPOSE: Estrogen receptor alpha (ER alpha )-positive breast cancer cell lines are up to 10 times more sensitive than ER alpha -negative cell lines to the... 
Journal Article
The FEBS Journal, ISSN 1742-464X, 08/2009, Volume 276, Issue 15, pp. 4037 - 4050
Journal Article